April 20, 2023
Private equity firm ACAS LLC and two Travelers units told a Maryland federal court Thursday that they have resolved their dispute over coverage for an underlying wrongful death suit connected to a tainted batch of blood-thinning drug heparin.
January 27, 2022
Private equity firm ACAS LLC told a Maryland federal court Thursday that Travelers cannot rely on a previous settlement to escape coverage for a lawsuit connected to a tainted batch of the blood thinner heparin because the disputed claims accrued only after that settlement.
January 06, 2022
Travelers told a Maryland federal court Thursday that it doesn't owe private equity firm ACAS LLC coverage for a wrongful death suit connected to a tainted batch of the blood thinner heparin, saying a settlement relieved it of any responsibilities.
July 21, 2020
Private equity firm ACAS LLC has told a Maryland federal judge that Travelers Property Casualty Co. of America is shirking its obligations by planning not to pay for a settlement in a wrongful death suit involving blood-thinning drug heparin.